Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
/PRNewswire/ -- AbbVie (NYSE: ABBV) hat heute die vorläufigen Ergebnisse der zulassungsrelevanten Phase-3-Studie ECLIPSE bekannt gegeben, in der die
AbbVie presentará datos de fase 3 de ECLIPSE en el 19º Congreso Europeo de Cefaleas
12:16pm, Monday, 01'st Dec 2025
- AbbVie presentará datos de fase 3 de ECLIPSE que demuestran la superioridad de Atogepant (AQUIPTA) sobre placebo para lograr la eliminación del dolor en el
AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" Rating
05:55am, Monday, 01'st Dec 2025
AbbVie (ABBV) remains a "Strong Buy" due to robust growth in immunology and neuroscience portfolios, offsetting Humira's decline. ABBV's oncology segment is poised for expansion with trispecific antib
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced primary results from the pivotal Phase 3 ECLIPSE study, evaluating the safety, efficacy and tolerability of
BLI Banque de Luxembourg Investments Has $1.82 Million Stock Holdings in AbbVie Inc. $ABBV
03:30am, Monday, 01'st Dec 2025
BLI Banque de Luxembourg Investments trimmed its position in AbbVie Inc. (NYSE: ABBV) by 15.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Comm
Boston Family Office LLC Has $13.36 Million Holdings in AbbVie Inc. $ABBV
03:30am, Monday, 01'st Dec 2025
Boston Family Office LLC lessened its position in AbbVie Inc. (NYSE: ABBV) by 0.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for Years
03:30pm, Saturday, 29'th Nov 2025
The stocks listed below yield between 2.7% and 3.5%. They are in different sectors of the economy and can help diversify your portfolio while also generating plenty of recurring cash flow.
Best Dividend Aristocrats For December 2025
08:02am, Saturday, 29'th Nov 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,
Berry Wealth Group LP Has $3.12 Million Stock Holdings in AbbVie Inc. $ABBV
03:27am, Saturday, 29'th Nov 2025
Berry Wealth Group LP increased its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 479.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Co
Balanced Wealth Group LLC Raises Stock Holdings in AbbVie Inc. $ABBV
03:26am, Saturday, 29'th Nov 2025
Balanced Wealth Group LLC lifted its holdings in shares of AbbVie Inc. (NYSE: ABBV) by 23.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Ex
SKYRIZI, un inhibiteur de l'interleukine 23 (IL-23), a fait l'objet de deux recommandations consécutives de l'Agence des médicaments du Canada (AMC) visant son remboursement pour le traitement des m
MONTREAL, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Today, AbbVie (NYSE: ABBV) has announced two positive updates for Canadians living with ulcerative colitis (UC).
8 Dividend Stocks Every Investor Should Consider
05:30am, Friday, 28'th Nov 2025
Dividend investing isn't just about yield -- payout ratio and growth potential matter too. Several of these companies have increased dividends for decades without interruption.
AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights
11:45am, Wednesday, 26'th Nov 2025
ABBV's surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
09:30am, Tuesday, 25'th Nov 2025
MONTREAL, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Today, AbbVie (NYSE: ABBV), jointly with the adMare BioInnovations, announced the launch of the AbbVie Biotech Innovators Award, a prize to help foster inno
